Since their discovery, researchers have repeatedly demonstrated the potential medical applications of differentiated cells and tissues generated from induced pluripotent stem (iPS) cells. However, a significant hurdle to real-world medical applications is related to the substrate used to culture and induce iPS cells into differentiated cell types.
Designing a novel substrate for myogenic differentiation from induced pluripotent stem cells
